Genetic Technologies, Wellworks for You sign B2B sales, marketing deal

Genetic Technologies announced the execution of a strategic joint sales & marketing agreement with US based Wellworks for You. As part of the agreement, Wellworks will incorporate the geneType portfolio of tests into its fully flexible, scalable employee wellness solutions for organizations and businesses across the U.S, providing direct access to more than two million personnel. Executing GTG’s inaugural Business to Business collaboration with U.S. based Wellworks facilitates the company’s entry into Wellworks’ expansive network of self-insured employers with the geneType Risk Assessment Test portfolio. Assuming a conservative adoption rate of 2% across the Wellworks network, we anticipate this collaboration will generate an impressive 40,000 units in geneType sales in the first year of implementation, potentially scaling to 5% or 100,000 tests in year three. This partnership marks a pivotal milestone in both the GTG and Wellworks expansion strategies. Wellworks provides a personalised approach for corporate wellness for U.S. employers and their employees. The partnership will provide access to Wellworks’ 750 employer groups and includes more than 2,000,000 covered lives. Wellworks will refer their clients, employer groups and their employees, to geneType for Risk Assessment Testing as part of their overall corporate wellness program.